Agree, we really need to see the OS data for this.
However I'm pretty sure it would be positive given the amount of collaborations taking place on HerVaxx. It would be highly unlikely big pharma wouldn't have access to this data in doing the dea
Also i'm not sure but recently read the article released by Ursula on the media thread and i believe she mentioned something with regards to the combination of this drug in mice being very effective..feel free to correct me if i'm wrong.
I
Ann: Imugene HER-Vaxx Clinical Trial Collaboration with Merck, page-13
-
- There are more pages in this discussion • 157 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
0.003(5.77%) |
Mkt cap ! $404.2M | |||
| Open | High | Low | Value | Volume |
| 5.2¢ | 5.7¢ | 5.2¢ | $802.5K | 14.79M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 348447 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 1214875 | 6 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |